Skip to main content
. 2020 Oct 2;21(19):7294. doi: 10.3390/ijms21197294

Figure 3.

Figure 3

Pre-treatment with ATA did not prevent infection by BTV or AHSV. (a) Schematic representation of the experimental design. Vero cells were pre-treated with the indicated concentrations of ATA for 24 or 48 h before infection (MOI, 0.01) with BTV (b) or AHSV (c). At 24 h.p.i, tissue culture supernatants were collected for virus titration by the plaque assay. Data re expressed as mean and SD. Dotted lines indicate the limit of detection.